Illustrative image – not actual.Strides Arcolab, a pharmaceutical company is mulling to raise its stake in an Australia based pharmaceutical company.
The company is likely to increase its stake from existing 58 to 94 per cent in Ascent Pharmahealth at a deal valued at A$36 million (approx Rs 162 crore). It has given an offer of $0.40 per share to minority shareholders. The proposed acquisition is to be funded through international debt which is expected to be completed by April 2011.
In April 2008, Strides had acquired 50.1 per cent stake in Ascent, through a swap arrangement in which the company sold its Singapore subsidiary to get the holding in Ascent. Subsequently, it raised its stake to 57 per cent in the company.
